Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John A. Latham currently holds 244,180 shares of ALDER BIOPHARMACEUTICALS INC (ALDR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John A. Latham has been a net seller of ALDR stock. They have purchased $0 and sold $9.5M worth of shares.
John A. Latham's most recent insider trade was on Nov 30, 2018, when they sold 487 shares at $9.35 per share.
John A. Latham serves as Executive at ALDER BIOPHARMACEUTICALS INC (ALDR). They have executed 82 insider transactions totaling $9.5M over their tenure at the company.
John A. Latham holds the position of Executive at ALDER BIOPHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
John A. Latham has shown a selling trading pattern, with $0 in total purchases and $9.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John A. Latham was on May 31, 2016, when they sold $1.0M worth of ALDR shares. This transaction involved 33,599 shares at $30.04 per share.
John A. Latham currently owns 244,180 shares of ALDER BIOPHARMACEUTICALS INC (ALDR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John A. Latham's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John A. Latham has 82 Form 4 filings on record as an insider at ALDER BIOPHARMACEUTICALS INC.
Set alerts for John A. Latham and 40,000+ other insiders.